We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
-$388M
Cap. Flow
-$87.6M
Cap. Flow %
-0.84%
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$120M
2
CHRD icon
Chord Energy
CHRD
+$106M
3
EA icon
Electronic Arts
EA
+$96.9M
4
DGX icon
Quest Diagnostics
DGX
+$89.2M
5
ST icon
Sensata Technologies
ST
+$76.1M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$138M
2
AVT icon
Avnet
AVT
+$130M
3
ERF
Enerplus Corporation
ERF
+$110M
4
PXD
Pioneer Natural Resource Co.
PXD
+$73.5M
5
HON icon
Honeywell
HON
+$72.8M

Sector Composition

Rank Sector Weight
1 Healthcare 42.43%
2 Technology 19.78%
3 Energy 7.84%
4 Industrials 7.21%
5 Financials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JANX icon
226
Janux Therapeutics
JANX
$934M
$12.6M 0.12%
300,825
+270,977
+908% +$12.7M
CP icon
227
Canadian Pacific Kansas City
CP
$79.7B
$12.2M 0.12%
+155,157
New +$12.6M
RCKT icon
228
Rocket Pharmaceuticals
RCKT
$372M
$12.1M 0.12%
+561,966
New +$12.9M
IRON icon
229
Disc Medicine
IRON
$2.93B
$12.1M 0.12%
+267,863
New +$9.1M
BCYC
230
Bicycle Therapeutics
BCYC
$270M
$11.9M 0.11%
+586,622
New +$13.3M
CNM icon
231
Core & Main
CNM
$8.56B
$11.5M 0.11%
235,159
-230,641
-50% -$12.8M
DVAX
232
DELISTED
Dynavax Technologies
DVAX
$11.3M 0.11%
1,006,027
-362,740
-27% -$4.22M
CRBP icon
233
Corbus Pharmaceuticals
CRBP
$165M
$11.3M 0.11%
249,259
+208,278
+508% +$8.76M
ARVN icon
234
Arvinas
ARVN
$520M
$11.3M 0.11%
423,124
+920
+0.2% +$29.3K
ESPR
235
DELISTED
Esperion Therapeutics
ESPR
$11.2M 0.11%
5,049,808
-2,872,421
-36% -$6.76M
NWLI
236
DELISTED
National Western Life Group, Inc. Class A
NWLI
$11.2M 0.11%
22,510
-24,291
-52% -$11.9M
IMNM icon
237
Immunome
IMNM
$2.61B
$11.2M 0.11%
922,892
-395,164
-30% -$6.18M
RARE icon
238
Ultragenyx Pharmaceutical
RARE
$2.46B
$11M 0.1%
266,790
-133,334
-33% -$5.69M
WCN
239
Waste Connections
WCN
$42.3B
$11M 0.1%
62,523
-48,862
-44% -$8.17M
AFG icon
240
American Financial Group
AFG
$11.8B
$10.9M 0.1%
88,846
+28,040
+46% +$3.61M
CYTK icon
241
Cytokinetics
CYTK
$10.4B
$10.7M 0.1%
+198,181
New +$12M
TVTX icon
242
Travere Therapeutics
TVTX
$5.11B
$10.5M 0.1%
+1,276,878
New +$8.6M
INSM icon
243
Insmed
INSM
$21.3B
$10.4M 0.1%
+155,155
New +$6.02M
JBHT icon
244
JB Hunt Transport Services
JBHT
$25.1B
$10.4M 0.1%
+64,885
New +$10.9M
DUOL icon
245
Duolingo
DUOL
$6.33B
$10.2M 0.1%
+48,743
New +$9.98M
ALLO icon
246
Allogene Therapeutics
ALLO
$635M
$10.2M 0.1%
4,358,989
+1,725,013
+65% +$5.09M
MLTX icon
247
MoonLake Immunotherapeutics
MLTX
$1.48B
$9.97M 0.1%
226,717
+19,302
+9% +$818K
TXRH icon
248
Texas Roadhouse
TXRH
$13.8B
$9.86M 0.09%
57,421
-109,391
-66% -$17.8M
ERAS icon
249
Erasca
ERAS
$6.19B
$9.76M 0.09%
4,134,036
+3,243,243
+364% +$7M
DAWN
250
DELISTED
Day One Biopharmaceuticals
DAWN
$9.75M 0.09%
707,531
+434,993
+160% +$6.36M
8 9
10
11 12

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.

  • Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
  • Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
  • Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
  • Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
  • Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
  • Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
  • Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.